Internal Medicine · Clovis, CA
NPI
1174896880
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2755 Herndon Ave
Clovis, CA, 93611
Phone (559) 228-4222
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
651 services
Medicare patients, 2024
177
Average age 75
Drug cost, 2024
$26K
186 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raquel S Salazar-Kagunye was code 99232 (hospital e&m - subsequent), 426 times for 143 patients. In total Raquel S Salazar-Kagunye billed 651 services in 5 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 426 | 143 | $62.26 | $27K |
| 99233 Hospital E&M - Subsequent | Facility | 163 | 72 | $93.46 | $15K |
| 99238 Hospital Discharge Management | Facility | 54 | 54 | $64.05 | $3,459 |
By year: 2022 $36K for 515 services; 2023 $38K for 567 services; 2024 $46K for 651 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raquel S Salazar-Kagunye prescribed most often to Medicare patients was Clinisol (Parenteral Amino Acid 15% No.5), with 33 prescriptions and refills. In total Raquel S Salazar-Kagunye wrote 186 Medicare prescriptions that cost $26K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clinisol Parenteral Amino Acid 15% No.5 | 33 | 33 | Under 11 | $13K |
Brand drugs: - claims; generic drugs: 160 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Raquel S Salazar-Kagunye were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.